Factors Related to Adherence to Opioids in Black Patients With Cancer Pain

Cancer pain relief is often inadequate because of poor adherence to pain medication, especially for black patients. The purpose of this study is to describe factors related to adherence to around-the-clock opioids among 110 black patients being treated for cancer pain. Sociodemographic, clinical, sy...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pain and symptom management 2019-01, Vol.57 (1), p.28-36
Main Authors: Yeager, Katherine A., Williams, Bryan, Bai, Jinbing, Cooper, Hannah L.F., Quest, Tammie, Meghani, Salimah H., Bruner, Deborah W.
Format: Article
Language:English
Subjects:
Adherence
African Americans
Analgesics, Opioid - therapeutic use
Black people
Black race
Cancer
Cancer pain
Cancer Pain - drug therapy
Cancer Pain - ethnology
Change agents
Chemotherapy
Cure
Drugs
electronic monitoring
Female
Follow-Up Studies
Humans
Male
Medication Adherence - ethnology
Middle Aged
Narcotics
Nausea
Opioids
Pain
Pain Management
Palliative Care
Patient compliance
Patients
Physicians
Prospective Studies
Severity
Social Support
Sociodemographics
Treatment preferences
Women
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer pain relief is often inadequate because of poor adherence to pain medication, especially for black patients. The purpose of this study is to describe factors related to adherence to around-the-clock opioids among 110 black patients being treated for cancer pain. Sociodemographic, clinical, symptoms, and social support data were collected at baseline; pain and adherence data were collected at 30 days. Associations between these variables and opioid adherence measured by Medication Event Monitoring System were estimated using multiple regression. Mean age was 56 (±10.1), the majority were women (63%) and college educated (56%). Mean pain severity at baseline equaled 4.6 (±2.3). Mean dose adherence was 60% (±28.5), while mean schedule adherence was 33.0% (±31.0). In adjusted analysis, 26% of the variance in dose adherence was explained by recent chemotherapy, changes in pain, concerns about nausea, and doctors' focus on cure versus pain control (P
ISSN:0885-3924
1873-6513
DOI:10.1016/j.jpainsymman.2018.10.491